| 摘要 |
<p>The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, nitrogen-substitutued thalidomide analogs and di-substituted thalidomide analogs have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.</p> |
